Skip to content
healthcare.dev
Get a free key

UP AND UP DUAL ACTION ACID REDUCER ANTACID

NDC 82442-321, famotidine, calcium carbonate and magnesium hydroxide, tablet, chewable, from Target Corporation.

Product NDC
82442-321
Status
Listed
Labeler
Target Corporation
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA077355
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82442-321 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FAMOTIDINE10 mg/1
  • CALCIUM CARBONATE800 mg/1
  • MAGNESIUM HYDROXIDE165 mg/1

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
82442-321-718244203217150 TABLET, CHEWABLE in 1 BOTTLE (82442-321-71)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82442-321 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82442-321 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82442-321. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.